Currently held
- Agent IX — Bear Equityshort159 sh @ $62.53 · stop $71.91+$0.00 unrealized
A paper-trading practice in the tradition of weekly Sunday charts.
Moat Strategies Join Tech-Led April Rebound
Moat Index gained 3.87%, lagging as underweight to tech hurt during a narrow rally. SMID Moat Index rose 6.18%, trailing small- and mid-cap benchmarks despite tech strength.
GE HealthCare To Showcase Next-Gen Technologies Including Helium-Free 1.5T MR, Advanced 3T Scanner And State-Of-The-Art AI-Powered Workflow At ISMRM 2026
As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (NASDAQ:GEHC) today announced advancements in research
GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact
CHICAGO, May 11, 2026--As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements.
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Boston Scientific Corporation outlook: EP share loss vs PFA leadership, Watchman & neuromod growth, improving margins and low valuation. Click for more on BSX.
A Look At GE HealthCare Technologies (GEHC) Valuation After Recent Share Price Weakness
Recent share performance and business context GE HealthCare Technologies (GEHC) has drawn attention after a period where the stock is down about 13% over the past month and roughly 20% over the past 3 months, prompting closer scrutiny from investors. The company reports annual revenue of US$20,979.0m and net income of US$1,909.0m, with operations spanning imaging, patient care solutions, pharmaceutical diagnostics and advanced visualization solutions across the United States, Canada, China,...
CGVV: An Interesting, New Value ETF Worth Watching
Capital Group US Large Value ETF: concentrated U.S. large-cap value fund beating VOO YTD. Read here for an investment analysis of CCGV ETF.
Is Wall Street Bullish or Bearish on GE HealthCare Technologies Stock?
While GE HealthCare Technologies has notably underperformed the S&P 500 over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions
CHICAGO, May 12, 2026--At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care.
GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools
GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Presenter SpeechTravis Steed Good morning everybody. This is Travis Steed, the Bank of America [ Mantech ] analyst. And next at Vegas conference, we have GE HealthCare. We have Jay Saccaro, CFO....
Do Options Traders Know Something About GE Healthcare Stock We Don't?
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
Moat Strategies Join Tech-Led April Rebound
Moat Index gained 3.87%, lagging as underweight to tech hurt during a narrow rally. SMID Moat Index rose 6.18%, trailing small- and mid-cap benchmarks despite tech strength.
GE HealthCare To Showcase Next-Gen Technologies Including Helium-Free 1.5T MR, Advanced 3T Scanner And State-Of-The-Art AI-Powered Workflow At ISMRM 2026
As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (NASDAQ:GEHC) today announced advancements in research
GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact
CHICAGO, May 11, 2026--As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements.
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Boston Scientific Corporation outlook: EP share loss vs PFA leadership, Watchman & neuromod growth, improving margins and low valuation. Click for more on BSX.
A Look At GE HealthCare Technologies (GEHC) Valuation After Recent Share Price Weakness
Recent share performance and business context GE HealthCare Technologies (GEHC) has drawn attention after a period where the stock is down about 13% over the past month and roughly 20% over the past 3 months, prompting closer scrutiny from investors. The company reports annual revenue of US$20,979.0m and net income of US$1,909.0m, with operations spanning imaging, patient care solutions, pharmaceutical diagnostics and advanced visualization solutions across the United States, Canada, China,...
CGVV: An Interesting, New Value ETF Worth Watching
Capital Group US Large Value ETF: concentrated U.S. large-cap value fund beating VOO YTD. Read here for an investment analysis of CCGV ETF.
Is Wall Street Bullish or Bearish on GE HealthCare Technologies Stock?
While GE HealthCare Technologies has notably underperformed the S&P 500 over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions
CHICAGO, May 12, 2026--At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care.
GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools
GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Presenter SpeechTravis Steed Good morning everybody. This is Travis Steed, the Bank of America [ Mantech ] analyst. And next at Vegas conference, we have GE HealthCare. We have Jay Saccaro, CFO....
Do Options Traders Know Something About GE Healthcare Stock We Don't?
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
Moat Strategies Join Tech-Led April Rebound
Moat Index gained 3.87%, lagging as underweight to tech hurt during a narrow rally. SMID Moat Index rose 6.18%, trailing small- and mid-cap benchmarks despite tech strength.
GE HealthCare To Showcase Next-Gen Technologies Including Helium-Free 1.5T MR, Advanced 3T Scanner And State-Of-The-Art AI-Powered Workflow At ISMRM 2026
As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (NASDAQ:GEHC) today announced advancements in research
GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact
CHICAGO, May 11, 2026--As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements.
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Boston Scientific Corporation outlook: EP share loss vs PFA leadership, Watchman & neuromod growth, improving margins and low valuation. Click for more on BSX.
A Look At GE HealthCare Technologies (GEHC) Valuation After Recent Share Price Weakness
Recent share performance and business context GE HealthCare Technologies (GEHC) has drawn attention after a period where the stock is down about 13% over the past month and roughly 20% over the past 3 months, prompting closer scrutiny from investors. The company reports annual revenue of US$20,979.0m and net income of US$1,909.0m, with operations spanning imaging, patient care solutions, pharmaceutical diagnostics and advanced visualization solutions across the United States, Canada, China,...
CGVV: An Interesting, New Value ETF Worth Watching
Capital Group US Large Value ETF: concentrated U.S. large-cap value fund beating VOO YTD. Read here for an investment analysis of CCGV ETF.
Is Wall Street Bullish or Bearish on GE HealthCare Technologies Stock?
While GE HealthCare Technologies has notably underperformed the S&P 500 over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions
CHICAGO, May 12, 2026--At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care.
GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools
GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Presenter SpeechTravis Steed Good morning everybody. This is Travis Steed, the Bank of America [ Mantech ] analyst. And next at Vegas conference, we have GE HealthCare. We have Jay Saccaro, CFO....
Do Options Traders Know Something About GE Healthcare Stock We Don't?
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
GE HealthCare To Showcase Next-Gen Technologies Including Helium-Free 1.5T MR, Advanced 3T Scanner And State-Of-The-Art AI-Powered Workflow At ISMRM 2026
As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (NASDAQ:GEHC) today announced advancements in research
GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact
CHICAGO, May 11, 2026--As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements.
GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning
GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Boston Scientific Corporation outlook: EP share loss vs PFA leadership, Watchman & neuromod growth, improving margins and low valuation. Click for more on BSX.
A Look At GE HealthCare Technologies (GEHC) Valuation After Recent Share Price Weakness
Recent share performance and business context GE HealthCare Technologies (GEHC) has drawn attention after a period where the stock is down about 13% over the past month and roughly 20% over the past 3 months, prompting closer scrutiny from investors. The company reports annual revenue of US$20,979.0m and net income of US$1,909.0m, with operations spanning imaging, patient care solutions, pharmaceutical diagnostics and advanced visualization solutions across the United States, Canada, China,...
CGVV: An Interesting, New Value ETF Worth Watching
Capital Group US Large Value ETF: concentrated U.S. large-cap value fund beating VOO YTD. Read here for an investment analysis of CCGV ETF.
Is Wall Street Bullish or Bearish on GE HealthCare Technologies Stock?
While GE HealthCare Technologies has notably underperformed the S&P 500 over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions
CHICAGO, May 12, 2026--At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care.
GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools
GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Presenter SpeechTravis Steed Good morning everybody. This is Travis Steed, the Bank of America [ Mantech ] analyst. And next at Vegas conference, we have GE HealthCare. We have Jay Saccaro, CFO....
Do Options Traders Know Something About GE Healthcare Stock We Don't?
Investors need to pay close attention to GEHC stock based on the movements in the options market lately.
Agent IX — Bear Equity — entry
Stage 4: close $62.53 < MA150 $76.49 (-18.2%), MA falling, 30.3% off 52w high, vol 0.04× avg
Agent II — Adaptive — considered
Stage 4: close $61.94 < MA150 $76.49 (-19.0%), MA falling, 31.0% off 52w high, vol 0.02× avg
Agent I — Immutable — considered
Stage 4: close $61.94 < MA150 $76.49 (-19.0%), MA falling, 31.0% off 52w high, vol 0.02× avg